Report cover image

Global Canine Vaccine Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 02, 2025
Length 113 Pages
SKU # APRC20102834

Description

Summary

According to APO Research, The global Canine Vaccine market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Canine Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Canine Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Canine Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Canine Vaccine include Biogenesis Bago, Boehringer Ingelheim, Durvet, NeoTech, Virbac, Pfizer, Jilin Five-Star Animal Health, JINHE and Wuhan Keqian Biology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Canine Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Vaccine.

The Canine Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Canine Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Canine Vaccine Segment by Company

Biogenesis Bago
Boehringer Ingelheim
Durvet
NeoTech
Virbac
Pfizer
Jilin Five-Star Animal Health
JINHE
Wuhan Keqian Biology
SINOVAC
Elanco
Merck Animal Health
RuiPu Bio-Technology
Zoetis
CAHIC

Canine Vaccine Segment by Type

Core Vaccines
Non-Core Vaccines

Canine Vaccine Segment by Application

Puppies
Adult Dogs

Canine Vaccine Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canine Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Canine Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canine Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Canine Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Canine Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

113 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Canine Vaccine Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Canine Vaccine Sales Estimates and Forecasts (2020-2031)
1.3 Canine Vaccine Market by Type
1.3.1 Core Vaccines
1.3.2 Non-Core Vaccines
1.4 Global Canine Vaccine Market Size by Type
1.4.1 Global Canine Vaccine Market Size Overview by Type (2020-2031)
1.4.2 Global Canine Vaccine Historic Market Size Review by Type (2020-2025)
1.4.3 Global Canine Vaccine Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Canine Vaccine Sales Breakdown by Type (2020-2025)
1.5.2 Europe Canine Vaccine Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Canine Vaccine Sales Breakdown by Type (2020-2025)
1.5.4 South America Canine Vaccine Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Canine Vaccine Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Canine Vaccine Industry Trends
2.2 Canine Vaccine Industry Drivers
2.3 Canine Vaccine Industry Opportunities and Challenges
2.4 Canine Vaccine Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Canine Vaccine Revenue (2020-2025)
3.2 Global Top Players by Canine Vaccine Sales (2020-2025)
3.3 Global Top Players by Canine Vaccine Price (2020-2025)
3.4 Global Canine Vaccine Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Canine Vaccine Major Company Production Sites & Headquarters
3.6 Global Canine Vaccine Company, Product Type & Application
3.7 Global Canine Vaccine Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Canine Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Canine Vaccine Players Market Share by Revenue in 2024
3.8.3 2023 Canine Vaccine Tier 1, Tier 2, and Tier 3
4 Canine Vaccine Regional Status and Outlook
4.1 Global Canine Vaccine Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Canine Vaccine Historic Market Size by Region
4.2.1 Global Canine Vaccine Sales in Volume by Region (2020-2025)
4.2.2 Global Canine Vaccine Sales in Value by Region (2020-2025)
4.2.3 Global Canine Vaccine Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Canine Vaccine Forecasted Market Size by Region
4.3.1 Global Canine Vaccine Sales in Volume by Region (2026-2031)
4.3.2 Global Canine Vaccine Sales in Value by Region (2026-2031)
4.3.3 Global Canine Vaccine Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Canine Vaccine by Application
5.1 Canine Vaccine Market by Application
5.1.1 Puppies
5.1.2 Adult Dogs
5.2 Global Canine Vaccine Market Size by Application
5.2.1 Global Canine Vaccine Market Size Overview by Application (2020-2031)
5.2.2 Global Canine Vaccine Historic Market Size Review by Application (2020-2025)
5.2.3 Global Canine Vaccine Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Canine Vaccine Sales Breakdown by Application (2020-2025)
5.3.2 Europe Canine Vaccine Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Canine Vaccine Sales Breakdown by Application (2020-2025)
5.3.4 South America Canine Vaccine Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Canine Vaccine Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Biogenesis Bago
6.1.1 Biogenesis Bago Comapny Information
6.1.2 Biogenesis Bago Business Overview
6.1.3 Biogenesis Bago Canine Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Biogenesis Bago Canine Vaccine Product Portfolio
6.1.5 Biogenesis Bago Recent Developments
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Comapny Information
6.2.2 Boehringer Ingelheim Business Overview
6.2.3 Boehringer Ingelheim Canine Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer Ingelheim Canine Vaccine Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments
6.3 Durvet
6.3.1 Durvet Comapny Information
6.3.2 Durvet Business Overview
6.3.3 Durvet Canine Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Durvet Canine Vaccine Product Portfolio
6.3.5 Durvet Recent Developments
6.4 NeoTech
6.4.1 NeoTech Comapny Information
6.4.2 NeoTech Business Overview
6.4.3 NeoTech Canine Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 NeoTech Canine Vaccine Product Portfolio
6.4.5 NeoTech Recent Developments
6.5 Virbac
6.5.1 Virbac Comapny Information
6.5.2 Virbac Business Overview
6.5.3 Virbac Canine Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Virbac Canine Vaccine Product Portfolio
6.5.5 Virbac Recent Developments
6.6 Pfizer
6.6.1 Pfizer Comapny Information
6.6.2 Pfizer Business Overview
6.6.3 Pfizer Canine Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Canine Vaccine Product Portfolio
6.6.5 Pfizer Recent Developments
6.7 Jilin Five-Star Animal Health
6.7.1 Jilin Five-Star Animal Health Comapny Information
6.7.2 Jilin Five-Star Animal Health Business Overview
6.7.3 Jilin Five-Star Animal Health Canine Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jilin Five-Star Animal Health Canine Vaccine Product Portfolio
6.7.5 Jilin Five-Star Animal Health Recent Developments
6.8 JINHE
6.8.1 JINHE Comapny Information
6.8.2 JINHE Business Overview
6.8.3 JINHE Canine Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 JINHE Canine Vaccine Product Portfolio
6.8.5 JINHE Recent Developments
6.9 Wuhan Keqian Biology
6.9.1 Wuhan Keqian Biology Comapny Information
6.9.2 Wuhan Keqian Biology Business Overview
6.9.3 Wuhan Keqian Biology Canine Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Wuhan Keqian Biology Canine Vaccine Product Portfolio
6.9.5 Wuhan Keqian Biology Recent Developments
6.10 SINOVAC
6.10.1 SINOVAC Comapny Information
6.10.2 SINOVAC Business Overview
6.10.3 SINOVAC Canine Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 SINOVAC Canine Vaccine Product Portfolio
6.10.5 SINOVAC Recent Developments
6.11 Elanco
6.11.1 Elanco Comapny Information
6.11.2 Elanco Business Overview
6.11.3 Elanco Canine Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Elanco Canine Vaccine Product Portfolio
6.11.5 Elanco Recent Developments
6.12 Merck Animal Health
6.12.1 Merck Animal Health Comapny Information
6.12.2 Merck Animal Health Business Overview
6.12.3 Merck Animal Health Canine Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Merck Animal Health Canine Vaccine Product Portfolio
6.12.5 Merck Animal Health Recent Developments
6.13 RuiPu Bio-Technology
6.13.1 RuiPu Bio-Technology Comapny Information
6.13.2 RuiPu Bio-Technology Business Overview
6.13.3 RuiPu Bio-Technology Canine Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 RuiPu Bio-Technology Canine Vaccine Product Portfolio
6.13.5 RuiPu Bio-Technology Recent Developments
6.14 Zoetis
6.14.1 Zoetis Comapny Information
6.14.2 Zoetis Business Overview
6.14.3 Zoetis Canine Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Zoetis Canine Vaccine Product Portfolio
6.14.5 Zoetis Recent Developments
6.15 CAHIC
6.15.1 CAHIC Comapny Information
6.15.2 CAHIC Business Overview
6.15.3 CAHIC Canine Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 CAHIC Canine Vaccine Product Portfolio
6.15.5 CAHIC Recent Developments
7 North America by Country
7.1 North America Canine Vaccine Sales by Country
7.1.1 North America Canine Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Canine Vaccine Sales by Country (2020-2025)
7.1.3 North America Canine Vaccine Sales Forecast by Country (2026-2031)
7.2 North America Canine Vaccine Market Size by Country
7.2.1 North America Canine Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Canine Vaccine Market Size by Country (2020-2025)
7.2.3 North America Canine Vaccine Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Canine Vaccine Sales by Country
8.1.1 Europe Canine Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Canine Vaccine Sales by Country (2020-2025)
8.1.3 Europe Canine Vaccine Sales Forecast by Country (2026-2031)
8.2 Europe Canine Vaccine Market Size by Country
8.2.1 Europe Canine Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Canine Vaccine Market Size by Country (2020-2025)
8.2.3 Europe Canine Vaccine Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Canine Vaccine Sales by Country
9.1.1 Asia-Pacific Canine Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Canine Vaccine Sales by Country (2020-2025)
9.1.3 Asia-Pacific Canine Vaccine Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Canine Vaccine Market Size by Country
9.2.1 Asia-Pacific Canine Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Canine Vaccine Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Canine Vaccine Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Canine Vaccine Sales by Country
10.1.1 South America Canine Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Canine Vaccine Sales by Country (2020-2025)
10.1.3 South America Canine Vaccine Sales Forecast by Country (2026-2031)
10.2 South America Canine Vaccine Market Size by Country
10.2.1 South America Canine Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Canine Vaccine Market Size by Country (2020-2025)
10.2.3 South America Canine Vaccine Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Canine Vaccine Sales by Country
11.1.1 Middle East and Africa Canine Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Canine Vaccine Sales by Country (2020-2025)
11.1.3 Middle East and Africa Canine Vaccine Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Canine Vaccine Market Size by Country
11.2.1 Middle East and Africa Canine Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Canine Vaccine Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Canine Vaccine Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Canine Vaccine Value Chain Analysis
12.1.1 Canine Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Canine Vaccine Production Mode & Process
12.2 Canine Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Canine Vaccine Distributors
12.2.3 Canine Vaccine Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.